The PIK3CA gene, coding for a subunit of the catalytic domain of PI3K, is often mutated or amplified in breast cancer, and therapeutic [58] inhibition of this pathway has shown some promising results in some types of breast cancer (Reviewed in [59]). Here, PIK3CA is linked to breast carcinoma.